N-Acetyl Cystein and Contrast Nephropathy

NCT01820195 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

549

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease Stage 2
Radiographic Contrast Agent Nephropathy

Interventions

DRUG: Oral N-Acetyl Cystein
DRUG: IV N-Acetyl Cystein
DRUG: Placebo group

Sponsor

Imam Khomeini Hospital

Collaborators

[object Object]